142 related articles for article (PubMed ID: 37736812)
21. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value and cost benefit of HPV testing for oropharyngeal cancer patients.
Lu XJD; Liu KYP; Prisman E; Wu J; Zhu YS; Poh C
Oral Dis; 2023 Mar; 29(2):483-490. PubMed ID: 34129700
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
24. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
25. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of p16 expression irrespective of human papillomavirus status in patients with oropharyngeal carcinoma.
Saito Y; Yoshida M; Omura G; Kobayashi K; Fujimoto C; Ando M; Sakamoto T; Asakage T; Yamasoba T
Jpn J Clin Oncol; 2015 Sep; 45(9):828-36. PubMed ID: 26056326
[TBL] [Abstract][Full Text] [Related]
27. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
Huang H; Zhang B; Chen W; Zou SM; Xu ZG
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
[TBL] [Abstract][Full Text] [Related]
29. Study of the concordance between p16 immunohistochemistry and HPV-PCR genotyping for the viral diagnosis of oropharyngeal squamous cell carcinoma.
Fonmarty D; Cherrière S; Fleury H; Eimer S; Majoufre-Lefebvre C; Castetbon V; de Monès E
Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Jun; 132(3):135-9. PubMed ID: 25687724
[TBL] [Abstract][Full Text] [Related]
30. Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results: Incidence and Characterization in a Large, Contemporary United States Cohort.
Shinn JR; Davis SJ; Lang-Kuhs KA; Rohde S; Wang X; Liu P; Dupont WD; Plummer D; Thorstad WL; Chernock RD; Mehrad M; Lewis JS
Am J Surg Pathol; 2021 Jul; 45(7):951-961. PubMed ID: 33739785
[TBL] [Abstract][Full Text] [Related]
31. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.
Al-Swiahb JN; Huang CC; Fang FM; Chuang HC; Huang HY; Luo SD; Chen CH; Chen CM; Chien CY
Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):502-8. PubMed ID: 20479383
[TBL] [Abstract][Full Text] [Related]
33. HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.
Lilja-Fischer JK; Kristensen MH; Lassen P; Steiniche T; Tramm T; Stougaard M; Maare C; Johansen J; Primdahl H; Kristensen CA; Andersen M; Eriksen JG; Overgaard J
Acta Oncol; 2023 Nov; 62(11):1384-1388. PubMed ID: 37837201
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
[TBL] [Abstract][Full Text] [Related]
35. p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status.
Lewis JS; Thorstad WL; Chernock RD; Haughey BH; Yip JH; Zhang Q; El-Mofty SK
Am J Surg Pathol; 2010 Aug; 34(8):1088-96. PubMed ID: 20588174
[TBL] [Abstract][Full Text] [Related]
36. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
[TBL] [Abstract][Full Text] [Related]
38. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
[TBL] [Abstract][Full Text] [Related]
39. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection.
Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962
[TBL] [Abstract][Full Text] [Related]
40. Population-based p16 and HPV positivity rates in oropharyngeal cancer in Southeast Scotland.
Wells LA; Junor EJ; Conn B; Pattle S; Cuschieri K
J Clin Pathol; 2015 Oct; 68(10):849-52. PubMed ID: 26152733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
